Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (1)
  • HER
    (4)
  • MEK
    (1)
  • Melanocortin Receptor
    (1)
  • PD-1/PD-L1
    (1)
  • Src
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

bms-599626 dihydrochloride

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | Activity
  • PROTAC Products
    2
    TargetMol | inventory
BMS-599626 2HCL(714971-09-2 Free base)
T2610L
BMS-599626 2HCL (AC480 2HCl) is a BMS-599626 derivative. BMS-599626 is an orally available and selective dual inhibitor of HER1 and HER2 with IC50s of 20 and 30 nM, respectively. BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor BMS-599626 inhibits tumor cell proliferation and has the potential to increase tumor response to radiotherapy.
  • $86
In Stock
Size
QTY
BMS 599626 2HCl (873837-23-1(HCl))
T53981781932-33-9
BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100-fold to Lck, VEGFR2, c-Kit, MET, etc.
  • $50
In Stock
Size
QTY
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride
T40111L2691796-83-3In house
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride, a resorcinol di-Ph ether scaffold-based programmed cell death-1 (PD-1) programmed cell death ligand 1 (PD-L1) inhibitor, inhibits the PD-1 PD-L1 interaction with an IC50 of 39.2 nM. It contains the target protein PD-1 PD-L1 ligand and PROTAC linker, which can be used to synthesize PROTAC PD-1 PD-L1 degrader-1 and has anticancer activity. Additionally, it serves as a diluent for the preparation of tablets for direct compression.
  • $222
In Stock
Size
QTY
BMS-599626
T2610714971-09-2
BMS-599626 (AC480) has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
  • $558
35 days
Size
QTY
BMS-599626 Hydrochloride
T5390873837-23-1
BMS-599626 Hydrochloride (AC480 Hydrochloride) is an orally bioavailable inhibitor of the HER1, HER2, and HER4 tyrosine kinases (IC50 = 22, 32, and 190 nM, respectively) with potential antineoplastic activity, inhibiting the proliferation of tumor cells that overexpress these receptors.
  • $37
In Stock
Size
QTY
BMS-470539 dihydrochloride
T105682341796-82-3
BMS-470539 dihydrochloride is a selective and highly potent melanocortin 1 receptor (MC-1 R) agonist with anti-inflammatory activity. BMS-470539 attenuates oxidative stress and neuronal apoptosis via the MC1R cAMP PKA Nurr1 signaling pathway in a neonatal hypoxia-ischemia rat model.
  • $52
6-8 weeks
Size
QTY
BMS-604992 dihydrochloride
T389591469750-46-6
BMS-604992 (EX-1314) dihydrochloride is a selective, orally active small-molecule agonist of the growth hormone secretagogue receptor (GHSR). It exhibits high-affinity binding (k i = 2.3 nM) and potent functional activity (EC 50 = 0.4 nM). Additionally, BMS-604992 dihydrochloride stimulates food intake in rodents.
  • $970
Backorder
Size
QTY
BMS-433771 dihydrochloride hydrate
T72105543700-67-0
BMS-433771 dihydrochloride hydrate is a potent, orally active inhibitor of respiratory syncytial virus (RSV), effective against both group A and B strains with an average EC50 of 20 nM, and is utilized in researching respiratory tract diseases.
  • $1,110
8-10 weeks
Size
QTY
BMS-1166-N-piperidine-CO-N-piperazine
T401112447066-14-8
BMS-1166-N-piperidine-CO-N-piperazine is a chemical compound containing a PD-1 PD-L1 immune checkpoint ligand and a PROTAC linker. It is used in synthesizing [PROTAC PD-1 PD-L1 degrader-1], which effectively inhibits the PD-1 PD-L1 interaction with an IC50 value of 39.2 nM.
  • Inquiry Price
Size
QTY